More tools:Markets·Screener·Research·Chat

Medifast, Inc. (MED) Financial Statements

Medifast, Inc.
SIC 2090 · MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS
FIGI BBG001SD45H4
XNYS · usd
12.16▼ 0.47 (-3.72%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close12.63
Day's Range12.12 – 12.64
52-Week Range9.21 – 14.67
Volume88.1K
Avg Volume159.5K
Share Statistics
Shares Outstanding
Employees380
ExchangeXNYS
Listed1981-03-24
Share count as of July 27, 2026
Loading Income Statement…
Key questions about Medifast, Inc. (MED)
What is Medifast, Inc.'s Market Cap?
Medifast, Inc.'s Market Cap is $136.0M, based on as-reported figures from SEC (XBRL) filings.
What is Medifast, Inc.'s Enterprise Value?
Medifast, Inc.'s Enterprise Value is -$33.9M, based on as-reported figures from SEC (XBRL) filings.
What is Medifast, Inc.'s Price / Sales?
Medifast, Inc.'s Price / Sales is 0.4×, based on as-reported figures from SEC (XBRL) filings.
What is Medifast, Inc.'s EV / Revenue?
Medifast, Inc.'s EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Medifast, Inc.'s EV / EBITDA?
Medifast, Inc.'s EV / EBITDA is 6.0×, based on as-reported figures from SEC (XBRL) filings.
What is Medifast, Inc.'s Revenue (TTM)?
Medifast, Inc.'s Revenue (TTM) is $316.9M, based on as-reported figures from SEC (XBRL) filings.
What is Medifast, Inc.'s Net Income (TTM)?
Medifast, Inc.'s Net Income (TTM) is -$25.6M, based on as-reported figures from SEC (XBRL) filings.
What is Medifast, Inc.'s EBITDA?
Medifast, Inc.'s EBITDA is -$5.7M, based on as-reported figures from SEC (XBRL) filings.
What is Medifast, Inc.'s Diluted EPS (TTM)?
Medifast, Inc.'s Diluted EPS (TTM) is -2.29, based on as-reported figures from SEC (XBRL) filings.
What is Medifast, Inc.'s EBITDA Margin?
Medifast, Inc.'s EBITDA Margin is -1.8%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth-27.6%-34.3%-36.9%-36.2%
Cost of sales
Gross profit
% of revenue69.9%68.1%69.4%69.5%
Selling, general, and administrative
Loss from operations
% of revenue-5.7%-4.3%-10.4%-4.6%
Other income
Interest income
Other income (expense)
Total other income (expense)
Income (loss) before provision for income taxes
Provision for income taxes
Net income (loss)
% of revenue-4.1%-2.8%-24.1%-2.5%
Basic (in usd per share)
Diluted (in usd per share)